Diclofenac Sodium/Eperisone Hydrochloride

双氯芬酸钠/盐酸乙哌立松

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDiclofenac Sodium/Eperisone Hydrochloride
Drug Alias NameEperisone/diclofenac盐酸乙哌立松/双氯芬酸钠Diclofenac Sodium and Eperisone HydrochlorideEperisone Hydrochloride and Diclofenac SodiumEprisan D SR
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsVoltage-gated calcium channel blockers
TargetsVoltage-gated calcium channelCyclooxygenases
Therapy Area/IndicationsBack Pain
Global Approved IndicationsBack Pain
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2012/01/01
Country/TerritoryIndia
CombinationsYes Diclofenac SodiumEperisone Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesEisai Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEisai Co Ltd
Inactive CompaniesN/A
Active IndicationsBack Pain
Inactive IndicationsN/A

Other Information

ATC CodeN02
Related LinksN/A